The company also wants to increase its sales by 19% to almost EUR 96 million. The profit should grow by 16% to EUR 12.1 million, according to the company’s budget.

The company will keep transferring the production of certain drugs from the main shareholder Sanofi, and will also try to diversify its export markets.

Last year, Zentiva Bucuresti made investments of EUR 2.65 million. The company’s exports reached 46% of its total sales in 2015, up from 40% in 2014. Zentiva’s turnover was EUR 89.3 million and the net profit was EUR 10.4 million, in 2015.

The company will pay EUR 9 million worth of dividends. (source: Romania-insider.com)